| [1] |
Wang K, Sun Q, Zhong X, et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis[J]. Cell, 2020, 180(5): 941-955.e20. DOI: 10.1016/j.cell.2020.02.002.
|
| [2] |
Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J]. Nature, 2017, 547(7661): 99-103. DOI: 10.1038/nature22393.
|
| [3] |
Wang W, Hu D, Feng Y, et al. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome[J]. BMC Biol, 2020, 18(1): 182. DOI: 10.1186/s12915-020-00918-w.
|
| [4] |
Shen S, He F, Cheng C, et al. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway[J]. Biomed Pharmacother, 2021, 133: 110990. DOI: 10.1016/j.biopha.2020.110990.
|
| [5] |
Wu G, Zhu Q, Zeng J, et al. Extracellular mitochondrial DNA promote NLRP3 inflammasome activation and induce acute lung injury through TLR9 and NF-κB[J]. J Thorac Dis, 2019, 11(11): 4816-4828. DOI: 10.21037/jtd.2019.10.26.
|
| [6] |
Jia Y, Cui R, Wang C, et al. Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway[J]. Redox Biol, 2020, 32: 101534. DOI: 10.1016/j.redox.2020.101534.
|
| [7] |
Ji X, Song Z, He J, et al. NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury[J]. Exp Cell Res, 2021, 398(2): 112418. DOI: 10.1016/j.yexcr.2020.112418.
|
| [8] |
Matikainen S, Nyman TA, Cypryk W. Function and regulation of noncanonical caspase-4/5/11 inflammasome[J]. J Immunol, 2020, 204(12): 3063-3069. DOI: 10.4049/jimmunol.2000373.
|
| [9] |
Sakhaei F, Keshvari M, Asgary S, et al. Enzymatic antioxidant system and endothelial function in patients with metabolic syndrome[J]. ARYA Atheroscler, 2020, 16(2): 94-101. DOI: 10.22122/arya.v16i2.1813.
|
| [10] |
Sachan A, Singh A, Shukla S, et al. Serum adipocytokines levels and their association with insulin sensitivity in morbidly obese individuals undergoing bariatric surgery[J]. J Obes Metab Syndr, 2020, 29(4): 303-312. DOI: 10.7570/jomes20090.
|
| [11] |
Huang D, Gao W, Zhong X, et al. NLRP3 activation in endothelia promotes development of diabetes-associated atherosclerosis[J]. Aging (Albany NY), 2020, 12(18): 18181-18191. DOI: 10.18632/aging.103666.
|
| [12] |
Li Y, Niu X, Xu H, et al. VX-765 attenuates atherosclerosis in apoE deficient mice by modulating VSMCs pyroptosis[J]. Exp Cell Res, 2020, 389(1): 111847. DOI: 10.1016/j.yexcr.2020.111847.
|
| [13] |
Lin Y, Hu Y, Hu X, et al. Ginsenoside Rb2 improves insulin resistance by inhibiting adipocyte pyroptosis[J]. Adipocyte, 2020, 9(1): 302-312. DOI: 10.1080/21623945.2020.1778826.
|
| [14] |
Wu D, Yan ZB, Cheng YG, et al. Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes[J]. Metabolism, 2018, 81: 1-12. DOI: 10.1016/j.metabol.2017.10.015.
|
| [15] |
Ghaneh T, Zeinali F, Babini H, et al. An increase in the expression of circulating miR30d-5p and miR126-3p is associated with intermediate hyperglycaemia in Iranian population[J]. Arch Physiol Biochem, 2020, 129(2): 489-496. DOI: 10.1080/13813455.2020.1839105.
|
| [16] |
Bukauskas T, Mickus R, Cereskevicius D, et al. Value of serum miR-23a, miR-30d, and miR-146a biomarkers in ST-elevation myocardial infarction[J]. Med Sci Monit, 2019, 25: 3925-3932. DOI: 10.12659/MSM.913743.
|
| [17] |
Xue S, Zhu W, Liu D, et al. Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction[J]. Mol Med, 2019, 25(1): 18. DOI: 10.1186/s10020-019-0086-1.
|
| [18] |
Shi P, Zhao XD, Shi KH, et al. MiR-21-3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor[J]. Exp Cell Res, 2021, 399(2): 112464. DOI: 10.1016/j.yexcr. 2020. 112464.
|
| [19] |
Xu Y, Fang H, Xu Q, et al. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR[J]. Cell Cycle, 2020, 19(22): 3054-3065. DOI: 10.1080/15384101.2020.1831245.
|
| [20] |
Wu A, Sun W, Mou F. lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression[J]. Mol Med Rep, 2021, 23(4): 259. DOI: 10.3892/mmr.2021.11898.
|
| [21] |
Yang F, Li A, Qin Y, et al. A novel circular rna mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA[J]. Mol Ther Nucleic Acids, 2019, 17: 636-643. DOI: 10.1016/j.omtn.2019.06.026.
|
| [22] |
Li P, Zhong X, Li J, et al. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis[J]. Biochem Biophys Res Commun, 2018, 503(4): 2833-2840. DOI: 10.1016/j.bbrc.2018.08.049.
|
| [23] |
Song J, Yang S, Yin R, et al. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL[J]. J Cell Biochem, 2019, 120(8): 13640-13650. DOI: 10.1002/jcb.28637.
|
| [24] |
Yang F, Qin Y, Wang Y, et al. Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy[J]. Int J Biol Sci, 2019, 15(5): 1010-1019. DOI: 10.7150/ijbs.29680.
|
| [25] |
Zhang J, Huang L, Shi X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway[J]. Aging (Albany NY), 2020, 12(23): 24270-24287. DOI: 10.18632/aging.202143.
|
| [26] |
Tang G, Duan F, Li W, et al. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE-/-mice[J]. Biomed Pharmacother, 2019, 119: 109410. DOI: 10.1016/j.biopha.2019.109410.
|
| [27] |
Zuo Y, Chen L, He X, et al. Atorvastatin regulates MALAT1/miR-200c/NRF2 activity to protect against podocyte pyroptosis induced by high glucose[J]. Diabetes Metab Syndr Obes, 2021, 14: 1631-1645. DOI: 10.2147/DMSO.S298950.
|
| [28] |
Luo M, Tan X, Mu L, et al. MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway[J]. Sci Rep, 2017, 7: 43427. DOI: 10.1038/srep43427.
|
| [29] |
Li H, Zhao Q, Liu R, et al. Protective effect and potential mechanism of simvastatin on myocardial injury induced by diabetes with hypoglycemia[J]. Exp Clin Endocrinol Diabetes, 2018, 126(3): 148-161. DOI: 10.1055/s-0043-110481.
|
京ICP备08002354号-3
